Acute Promyelocytic Leukemia: Molecular Genetics, Mouse by P. P. Pandolfi (auth.), Pier Paolo Pandolfi MD, Ph.D., Peter PDF

By P. P. Pandolfi (auth.), Pier Paolo Pandolfi MD, Ph.D., Peter K. Vogt Ph.D. (eds.)

ISBN-10: 3540345922

ISBN-13: 9783540345923

ISBN-10: 3540345949

ISBN-13: 9783540345947

(will follow)

Show description

Read Online or Download Acute Promyelocytic Leukemia: Molecular Genetics, Mouse Models and Targeted Therapy PDF

Similar therapy books

Download e-book for iPad: Current Therapy of Trauma and Surgical Critical Care by Asensio J.A., Trunkey D.D.

Evidence-based method of difficulties encountered in trauma and significant care surgical occasions

S. Redshaw, N. A. Roberts, G. J. Thomas (auth.), Professor's Proteases as Targets for Therapy PDF

This quantity is the 1st to mix newest details on viral, microbial and mobile proteolytic enzymes as strength goals for human therapeutics. Proteases keep watch over a wide array of physiological reactions, and are occupied with a number of pathological strategies for which potent medicines are at the moment wanted and/or being wanted.

Additional resources for Acute Promyelocytic Leukemia: Molecular Genetics, Mouse Models and Targeted Therapy

Example text

J. McConnell · J. D. Licht 46. Licht JD, Shaknovich R, English MA, Melnick A, Li JY, Reddy JC, Dong S, Chen SJ, Zelent A, Waxman S (1996) Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)associated acute promyelocytic leukemia. Oncogene 12:323–336 47. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM (1998) Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391:811–814 48. Reference deleted in proof 49.

This strongly supports the hypothesis that loss of PLZF leads to unrestricted exit from quiescence, diminishing the stem cell pool and causing premature progenitor loss due to the limited proliferative potential of committed progenitor cells. This effect of PLZF might be relevant to APL. Loss of one allele of PLZF might lead to deregulation of the stem cell; a decision in favor of proliferation may be made rather than quiescence. In this regard we note that while PLZF is a growth suppressor, the RARα-PLZF oncoprotein, which can bind to many of the same DNA-binding sites of wildtype PLZF, activates genes that PLZF represses and induces a myeloproliferative disease in mice.

Blood 91:2634–2642 25. Reference deleted in proof 26. Han SH, Jeon JH, Ju HR, Jung U, Kim KY, Yoo HS, Lee YH, Song KS, Hwang HM, Na YS, Yang Y, Lee KN, Choi I (2003) VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22:4035–4046 27. Hay RT (2005) SUMO: a history of modification. Mol Cell 18:1–12 28. He L, Bhaumik M, Tribioli C, Rego EM, Ivins S, Zelent A, Pandolfi PP (2000) Two critical hits for promyelocytic leukemia.

Download PDF sample

Acute Promyelocytic Leukemia: Molecular Genetics, Mouse Models and Targeted Therapy by P. P. Pandolfi (auth.), Pier Paolo Pandolfi MD, Ph.D., Peter K. Vogt Ph.D. (eds.)


by John
4.2

Rated 4.96 of 5 – based on 15 votes